Jakub Adamski, attornet-at-law, LL.M. Previously an EU policy expert at the Drug Policy and Pharmacy Department of the Ministry of Health in Poland. Where he was responsible for pricing and reimbursement of pharmaceuticals. Specialized in hospital reimbursement and orphan drugs. He was a member of the Rare Diseases Team, an advisory body to the Minister of Health. Adamski was an expert on pricing and reimbursement delegated to various EU Council and European Commission's working groups. He was an appointed member to the European Union Committee of Experts on Rare Diseases and a member of the EU intergovernmental networks, responsible for exchange of information with EU Member States autho...
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
